Safety assessment was based upon physical examinations, abdominal ultrasound, EKG, thoracic X-ray and full clinical chemistry and hematology. Adverse events or side effects were also monitored.

All clinical chemistry and hematology tests following 30 days of treatment were found to be normal. All physical examinations, including abdominal ultrasound, EKG's and X-Rays were found to be in normal ranges following treatment. There was no sign of allergic responses or any form of anaphylactic response. The safety report was issued by the Ministry of Health June 2, 1999.